Vivos RDGL
OTC RDGL
$0.05 +0.01 (+25.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vivos (RDGL) Accumulated Expenses (2014 - 2017)

Updated

Vivos' Accumulated Expenses came in at $28,846 for Q2 2017.

Analysis

Vivos (RDGL) Accumulated Expenses (2014 - 2017) Analysis & Trends

At the end of FY2014, Vivos' Accumulated Expenses was $228,300.

  • The Q2 2017 figure represents the highest quarterly Accumulated Expenses since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Vivos 22.77 Mn 13.09 Mn -3,105.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 28,846.00
Sep 30, 2015 359,344.00
Jun 30, 2015 346,276.00
Dec 31, 2014 228,300.00
API Access

Vivos Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RDGL&period=max&api_key=YOUR_API_KEY